SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-322051
Filing Date
2013-08-07
Accepted
2013-08-06 18:12:07
Documents
3
Group Members
ANSBERT GADICKEJAMES PAUL SCOPAJOHN VANDER VORTLUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCTODD FOLEYVAUGHN M. KAILIAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d581263dsc13d.htm SC 13D 239048
2 EX-B d581263dex991.htm EX-99.1 14246
3 EX-C d581263dex992.htm EX-99.2 12338
  Complete submission text file 0001193125-13-322051.txt   267478
Mailing Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 (617) 425-9200
MPM BIOVENTURES V, L.P. (Filed by) CIK: 0001482716 (see all company filings)

IRS No.: 270793842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87524 | Film No.: 131014648
SIC: 2834 Pharmaceutical Preparations